Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

William W. Busse, Ronald Dahl, Christine Jenkins, Alvaro A. Cruz
European Respiratory Review 2016 25: 54-64; DOI: 10.1183/16000617.0052-2015
William W. Busse
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wwb@medicine.wisc.edu
Ronald Dahl
2Allergy Centre, Odense University Hospital, Odense, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Jenkins
3The George Institute for Global Health, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alvaro A. Cruz
4ProAR – Universidade Federal da Bahia, Bahia, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 139 54-64
DOI 
https://doi.org/10.1183/16000617.0052-2015
PubMed 
26929422

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received June 23, 2015
  • Accepted August 10, 2015
  • Published online February 29, 2016.

Copyright & Usage 
Copyright ©ERS 2016. ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. William W. Busse1⇑,
  2. Ronald Dahl2,
  3. Christine Jenkins3 and
  4. Alvaro A. Cruz4
  1. 1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
  2. 2Allergy Centre, Odense University Hospital, Odense, Denmark
  3. 3The George Institute for Global Health, Sydney, Australia
  4. 4ProAR – Universidade Federal da Bahia, Bahia, Brazil
  1. William W. Busse, University of Wisconsin, K4/910, 9988 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA. E-mail: wwb{at}medicine.wisc.edu
View Full Text

Article usage

Article usage: February 2016 to July 2022

AbstractFullPdf
Feb 2016031
Mar 201671850601
Apr 201639428236
May 201632461192
Jun 201617271134
Jul 20161218898
Aug 20162816184
Sep 201649153180
Oct 20165144176
Nov 20164228963
Dec 20163511551
Jan 20173220265
Feb 20172723659
Mar 20172623060
Apr 20172319950
May 20173318646
Jun 20172013357
Jul 20172717755
Aug 20171217463
Sep 20171615835
Oct 20171417441
Nov 2017324640
Dec 2017312118
Jan 2018410911
Feb 2018512317
Mar 2018515229
Apr 2018517032
May 2018618623
Jun 2018026117
Jul 2018020815
Aug 2018017313
Sep 2018121624
Oct 2018140321
Nov 2018155422
Dec 2018131320
Jan 2019524320
Feb 2019723326
Mar 20191723734
Apr 2019616038
May 20191014426
Jun 2019214922
Jul 2019613321
Aug 2019911918
Sep 20191411222
Oct 2019520022
Nov 2019513324
Dec 2019210418
Jan 202039312
Feb 2020010815
Mar 20201025619
Apr 20201723122
May 20201312919
Jun 2020812222
Jul 2020711329
Aug 202029329
Sep 2020514619
Oct 2020218121
Nov 2020814233
Dec 2020415624
Jan 2021917925
Feb 2021216740
Mar 2021716017
Apr 2021510418
May 202139313
Jun 202139810
Jul 2021511718
Aug 202139112
Sep 202198523
Oct 202179638
Nov 202114938
Dec 202156923
Jan 202238115
Feb 202248913
Mar 2022423314
Apr 202256011
May 202235923
Jun 20222505
Jul 20221478

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 25 Issue 139 Table of Contents
European Respiratory Review: 25 (139)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
William W. Busse, Ronald Dahl, Christine Jenkins, Alvaro A. Cruz
European Respiratory Review Mar 2016, 25 (139) 54-64; DOI: 10.1183/16000617.0052-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?
William W. Busse, Ronald Dahl, Christine Jenkins, Alvaro A. Cruz
European Respiratory Review Mar 2016, 25 (139) 54-64; DOI: 10.1183/16000617.0052-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction: the unmet need in asthma management
    • Anticholinergics in the treatment of asthma
    • Summary and conclusions
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • COPD and smoking
  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Medications for the treatment of pulmonary arterial hypertension
  • Air pollution, metabolites and respiratory health across the life-course
  • Air pollution as an early determinant of COPD
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2022 by the European Respiratory Society